Shares of Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $6.95 and traded as low as $5.50. Mannatech shares last traded at $5.70, with a volume of 7,293 shares changing hands.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded shares of Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, May 26th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of “Sell”.
Check Out Our Latest Analysis on MTEX
Mannatech Price Performance
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.49 EPS for the quarter. Mannatech had a negative net margin of 11.97% and a negative return on equity of 2,383.34%. The company had revenue of $24.92 million during the quarter.
Insider Activity at Mannatech
In other news, Director Kevin Andrew Robbins acquired 7,100 shares of the business’s stock in a transaction dated Tuesday, May 19th. The stock was bought at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the transaction, the director owned 33,333 shares of the company’s stock, valued at $138,998.61. The trade was a 27.07% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders have purchased 14,903 shares of company stock valued at $62,155 in the last three months. 41.50% of the stock is currently owned by company insiders.
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Featured Stories
- Five stocks we like better than Mannatech
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
